Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of pterostilbene in anti-influenza virus drugs

A type of influenza A virus, influenza virus technology, applied in the direction of antiviral agents, ether/acetal active ingredients, etc., can solve problems such as universal drug resistance

Active Publication Date: 2022-06-24
GUANGDONG NO 2 PROVINCIAL PEOPLES HOSPITAL
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The former can only inhibit influenza A virus, but is ineffective against influenza B virus. It has been used clinically for many years and has led to widespread drug resistance. Therefore, alkanes are no longer the first choice for clinical treatment of influenza.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of pterostilbene in anti-influenza virus drugs
  • Application of pterostilbene in anti-influenza virus drugs
  • Application of pterostilbene in anti-influenza virus drugs

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] Pterostilbene for respiratory epithelial cells and toxicity assessment:

[0037] A549 cells were plated at 1 × 10 4 Inoculated in a 96-well plate / well at 37°C, 5% CO 2 Incubate overnight in incubator;

[0038] The supernatant was discarded from the cells, and the doubling-diluted pterostilbene was added to the lung epithelial cells (A549);

[0039] The cytotoxicity of pterostilbene on airway epithelial cells was detected by MTT method: After 48 hours, the supernatant was discarded, and the medium containing 0.5 mg / ml MTT was added to each well, and after incubation at 37 °C for 4 hours, the microplate reader was used to detect the OD570 nm. absorbance.

[0040] like figure 2 As shown, the experimental results showed that pterostilbene was less toxic to A549 cells, and the cell viability was >75% at the maximum concentration of 200 μM.

Embodiment 2

[0042] Evaluation of pterostilbene for respiratory epithelial cells and the ability to inhibit virus infection:

[0043] 1) Divide A549 cells into 3 x 10 5 Inoculated in a 6-well plate / well at 37°C, 5% CO 2 Incubate overnight in incubator;

[0044] 2) Discard the supernatant from the cells, dilute the virus with serum-free RPMI1640 medium, inoculate A549 cells with a virus titer of MOI=1, and adsorb in a 37°C, 5% CO2 incubator for 1 hour;

[0045] 3) After virus infection, discard the virus supernatant, add pterostilbene 40 times diluted in serum-free RPMI16 to the cells, at 37°C, 5% CO 2 Continue to cultivate in the incubator;

[0046] 4) After 24 hours, a) collect cell proteins, and use western blot to detect the expressions of influenza virus-related proteins NP, M2 and PB2. The results are as follows image 3 Compared with the virus control group, the expression levels of influenza virus proteins NP, PB2 and M2 were lower than those in the control group after adding pt...

Embodiment 3

[0051] Pterostilbene is used for respiratory epithelial cells and detection of NP expression:

[0052] 1) A549 cells at 2 x 10 4 Cells / well were seeded in confocal Petri dishes under 5% CO. 2 , cultured in a cell incubator at 37°C for 24h;

[0053] 2) Discard the culture supernatant, wash twice with PBS, add 200 μL of virus solution (MOI=1), in 5% CO 2 , cells were adsorbed in a cell incubator at 37°C for 1 h;

[0054] 3) Discard the virus solution, add the compound of the specified concentration to the petri dish, set up cell control wells and virus control wells, and continue to culture for 24 hours;

[0055] 4) Discard the supernatant and wash 3 times with pre-cooled PBS;

[0056] 5) Fixation and blocking of cells: add 200 μL of 4% paraformaldehyde to each well for 20 minutes, wash 3 times with PBS, and block with 200 μL of 3% bovine serum albumin for 1 hour at room temperature;

[0057] 6) Incubation with primary antibody: discard the blocked bovine serum albumin solu...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of anti-influenza virus applications, and in particular relates to the application of pterostilbene in anti-influenza A virus drugs. An application of pterostilbene in anti-influenza A virus drugs, the monomer pterostilbene targets influenza virus non-structural protein NS1, inhibits host PI3K / Akt signaling pathway activation, plays an antiviral effect, and can be used to prepare prophylactic and A drug for treating influenza; the monomer pterostilbene can be used as a lead compound for structural modification to obtain a compound with better activity and make it into an anti-influenza virus drug. As a natural monomer, pterostilbene provides a new small molecule natural drug for the prevention and treatment of influenza virus diseases, which can inhibit the infection of host cells by influenza A virus, thus providing a new method for the prevention and treatment of influenza virus diseases. It is a new way and means, which has important research and development value and development significance.

Description

technical field [0001] The invention belongs to the technical field of anti-influenza virus applications, in particular to the application of pterostilbene in anti-influenza A virus drugs. Background technique [0002] Influenza (influenza for short) is a respiratory infectious disease caused by influenza virus. It has the characteristics of high incidence, widespread prevalence and rapid spread. It poses a serious threat and burden to social health and economy. According to the statistics of the World Health Organization , seasonal influenza can cause approximately 3 million to 5 million severe cases and 300,000 to 500,000 deaths each year. [0003] Vaccination is the main line of defense and the most effective way to prevent influenza virus infection. Since the antigenicity of influenza A virus is prone to mutation, the autoimmune memory that has been formed in the body is invalid. and vaccination of new vaccines, greatly limiting the preventive effect of vaccines. The u...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/09A61P31/16
CPCA61K31/09A61P31/16
Inventor 武文姣刘群方智新许长鹏林剑国刘叔文
Owner GUANGDONG NO 2 PROVINCIAL PEOPLES HOSPITAL